NeuroPace Revenue and Competitors
Estimated Revenue & Valuation
- NeuroPace's estimated annual revenue is currently $71.5M per year.
- NeuroPace's estimated revenue per employee is $313,750
- NeuroPace's total funding is $247.3M.
Employee Data
- NeuroPace has 228 Employees.
- NeuroPace grew their employee count by 1% last year.
NeuroPace Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $19.1M | 76 | -3% | N/A | N/A |
#2 | $8M | 32 | -6% | N/A | N/A |
#3 | $5M | 20 | -9% | N/A | N/A |
#4 | $8.5M | 34 | 6% | N/A | N/A |
#5 | $5.3M | 21 | -9% | N/A | N/A |
#6 | $49.7M | 198 | 0% | N/A | N/A |
#7 | $12M | 48 | N/A | N/A | N/A |
#8 | $8.5M | 34 | 21% | N/A | N/A |
#9 | $30.1M | 120 | 22% | N/A | N/A |
#10 | $56.8M | 149 | 9% | $199.1M | N/A |
What Is NeuroPace?
NeuroPace was founded to design, develop, manufacture and market implantable devices for the treatment of neurological disorders by responsive brain stimulation. The company's initial focus is the treatment of epilepsy, a debilitating neurological disorder affecting approximately 1% of the population worldwide. Patients are currently being enrolled in a clinical trial of the company's Responsive Neurostimulator (RNS™) system for treating medically refractory epilepsy.
keywords:Biotechnology
$247.3M
Total Funding
228
Number of Employees
$71.5M
Revenue (est)
1%
Employee Growth %
N/A
Valuation
N/A
Accelerator
NeuroPace's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chairman The Board | |
2 | CFO, VP Finance & Administration | |
3 | Director Information Technology | |
4 | Corporate Controller | |
5 | Therapy Consultant | |
6 | Sr. Product Release Specialist | |
7 | Principal Field Clinical Engineer, Lead Field Clinical Engineer-Central Region, and Field Trainer | |
8 | Therapy Consultant-Great Lakes Region | |
9 | Therapy Consultant | |
10 | Principle Therapy Consultant |
NeuroPace News
NeuroPace Inc; Mindmaze SA; CTRL-Labs (Facebook); BrainCo; Brain Products GmbH; G.TEC; Emotiv Inc; Blackrock Microsystems LLC; InteraXon...
NeuroPace, Inc operates as a medical device company in the United States. The company develops and sells RNS system, a brain-responsive...
MOUNTAIN VIEW, Calif., April 21, 2022 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming...
Other Companies in Mountain View
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $32.6M | 228 | 12% | N/A |
#2 | $102.1M | 232 | -1% | N/A |
#3 | $53.2M | 236 | 1% | N/A |
#4 | $38.1M | 239 | 0% | N/A |
#5 | $64.7M | 240 | 30% | N/A |
NeuroPace Executives
| Name | Title |
|---|---|
| Rebecca Kuhn | CFO, VP Finance & Administration |
| Michael Favet | President and CEO |
| Maritza Lemus | Executive Assistant to the CEO and to the Vice President, Sales |
| Martha Morrell | Chief Medical Officer |
| Frank Fischer | President and CEO |
| Elton Cannon | Chief Financial Officer and Vice President |
| Martha Morrell | Chief Medical Officer |
| Rebecca Kuhn | CFO, VP Finance & Administration |
| Irene Thomas | Vice President, Human Resources |
| Uzair Siddiqui | Vice President, Product Development |
| Michael Favet | President and CEO |
| Maritza Lemus | Executive Assistant to the CEO and to the Vice President, Sales |
| Tim Proulx | Vice President Of Product Development |
| Mark Saxton | Vice President of Sales |
| Chi Nguyen | Vice President, Marketing |
| Dylan St. John | VP, Commercial and Manufacturing Operations |
| Frank Fischer | President and CEO |
| Irene Holloway | Vice President, Human Resources & Corporate Services |
| Isabella Abati | Vice President Regulatory Affairs |
| Elton Cannon | Chief Financial Officer and Vice President |